The Theophylline Extended-Release Ta, cataloged under National Stock Number 6505-01-201-0809, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 3 specifications, cited from the U.S. Government catalog. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-201-0809 |
| Item Name | Theophylline Extended-Release Ta |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| NDC00049-2200-66 | 3/1 Design control — primary reference Roerig Div Pfizer Inc |
| SUSTAIRE TABLETS | 5/1 Secondary reference Roerig Div Pfizer Inc |
NSN 6505-01-201-0809 is a Theophylline Extended-Release Ta, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-201-0809: Primary Container Content Quantity: 100.000 TABLETS; Primary Container Type: BOTTLE; Special Features: LONG ACTION METHOD:EXTENDED RELEASE;; Active Medicament Medicinal Strength: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.